Odedina Folakemi T, Warrick Cynthia, Vilme Helene, Young Steven
Economic Social & Administrative Pharmacy, Suite 200 Dyson Pharmacy Building, College of Pharmacy & Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL 32307, USA.
Res Social Adm Pharm. 2008 Mar;4(1):59-66. doi: 10.1016/j.sapharm.2007.03.001.
Community pharmacist involvement in health communication could assist in ameliorating health disparities in a number of areas. One such area is the early detection of prostate cancer in patients.
The primary goal of this study was to explore the role of pharmacists as health educators and risk communicators in the prevention of prostate cancer mortality. The study objectives were to (1) describe community pharmacists' attitudes and beliefs related to serving as health educators and risk communicators on prostate cancer; and (2) assess community pharmacists' knowledge about prostate cancer.
A cross-sectional survey methodology was used to collect data from pharmacists present at the Florida Pharmacy Association 115th Annual Meeting. Eighty-nine pharmacists were administered a survey to measure their knowledge, attitudes, and beliefs using a structured survey form. Descriptive statistics and multiple regression analyses were used to analyze participants' responses.
The mean age of participants was 45 years and they were mostly male, White (non-Hispanic) with B.S. Pharmacy as the highest degree. The face validity of the survey instrument was established through pilot test. Participants' views about offering prostate cancer education for patients were generally positive; however, participants' score on the general prostate cancer knowledge scale for patients was lower than expected for health care professionals, with approximately 45% of the participating pharmacists scoring less than 80% on the Odedina Prostate Cancer Screening Behavior Scale. Based on multiple regression analyses, participants' gender and disease state management status were found to be significantly associated with prostate cancer knowledge, whereas prostate cancer knowledge, technician staffing, and the type of pharmacy significantly predicted pharmacists' interest in prostate cancer education.
Although the community pharmacists in this study were willing to take on responsibilities in the prevention and detection of prostate cancer, their knowledge base may serve as an impediment to action. Future research may identify means by which to educate pharmacists and enable their involvement.
社区药剂师参与健康传播有助于改善多个领域的健康差异。其中一个领域是患者前列腺癌的早期检测。
本研究的主要目标是探讨药剂师作为健康教育者和风险沟通者在预防前列腺癌死亡方面的作用。研究目的包括:(1)描述社区药剂师对于担任前列腺癌健康教育者和风险沟通者的态度和信念;(2)评估社区药剂师关于前列腺癌的知识。
采用横断面调查方法,从参加佛罗里达药剂师协会第115届年会的药剂师中收集数据。使用结构化调查问卷对89名药剂师进行调查,以测量他们的知识、态度和信念。采用描述性统计和多元回归分析来分析参与者的回答。
参与者的平均年龄为45岁,他们大多为男性、白人(非西班牙裔),最高学历为药学学士。通过预试验确定了调查问卷的表面效度。参与者对于为患者提供前列腺癌教育的看法总体上是积极的;然而,参与者在针对患者的前列腺癌一般知识量表上的得分低于医疗保健专业人员的预期,约45%的参与药剂师在奥迪纳前列腺癌筛查行为量表上的得分低于80%。基于多元回归分析,发现参与者的性别和疾病状态管理状况与前列腺癌知识显著相关,而前列腺癌知识、技术人员配备和药房类型显著预测了药剂师对前列腺癌教育的兴趣。
尽管本研究中的社区药剂师愿意承担前列腺癌预防和检测方面的责任,但他们的知识基础可能成为行动的障碍。未来的研究可能会确定对药剂师进行教育并促使他们参与的方法。